Testicular cancer from diagnosis to epigenetic factors

Mariarosaria Boccellino, Daniela Vanacore, Silvia Zappavigna, Carla Cavaliere, Sabrina Rossetti, Carmine D'Aniello, Paolo Chieffi, Evzen Amler, Carlo Buonerba, Giuseppe Di Lorenzo, Rossella Di Franco, Alessandro Izzo, Raffaele Piscitelli, Gelsomina Iovane, Paolo Muto, Gerardo Botti, Sisto Perdonà, Michele Caraglia, Gaetano Facchini

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Testicular cancer (TC) is one of the most common neoplasms that occurs in male and includes germ cell tumors (GCT), sex cord-gonadal stromal tumors and secondary testicular tumors. Diagnosis of TC involves the evaluation of serum tumor markers alpha-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase, but clinically several types of immunohistochemical markers are more useful and more sensitive in GCT, but not in teratoma. These new biomarkers are genes expressed in primordial germ cells/gonocytes and embryonic pluripotency-related cells but not in normal adult germ cells and they include PLAP, OCT3/4 (POU5F1), NANOG, SOX2, REX1, AP-2γ (TFAP2C) and LIN28. Gene expression in GCT is regulated, at least in part, by DNA and histone modifications, and the epigenetic profile of these tumours is characterised by genome-wide demethylation. There are different epigenetic modifications in TG-subtypes that reflect the normal developmental switch in primordial germ cells from an under- to normally methylated genome. The main purpose of this review is to illustrate the findings of recent investigations in the classification of male genital organs, the discoveries in the use of prognostic and diagnostic markers and the epigenetic aberrations mainly affecting the patterns of DNA methylation/histone modifications of genes (especially tumor suppressors) and microRNAs (miRNAs).

Original languageEnglish
Pages (from-to)104654-104663
Number of pages10
JournalOncotarget
Volume8
Issue number61
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Testicular Neoplasms
Histone Code
Epigenomics
Germ Cell and Embryonal Neoplasms
Germ Cells
Sex Cord-Gonadal Stromal Tumors
Biomarkers
Genome
Male Genitalia
Teratoma
alpha-Fetoproteins
DNA Methylation
Chorionic Gonadotropin
Tumor Biomarkers
Tumor Suppressor Genes
MicroRNAs
L-Lactate Dehydrogenase
Neoplasms
Gene Expression
DNA

Keywords

  • Biomarkers
  • Epigenetic factors
  • Germ cell neoplasia
  • Seminoma
  • Testicular cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Boccellino, M., Vanacore, D., Zappavigna, S., Cavaliere, C., Rossetti, S., D'Aniello, C., ... Facchini, G. (2017). Testicular cancer from diagnosis to epigenetic factors. Oncotarget, 8(61), 104654-104663. https://doi.org/10.18632/oncotarget.20992

Testicular cancer from diagnosis to epigenetic factors. / Boccellino, Mariarosaria; Vanacore, Daniela; Zappavigna, Silvia; Cavaliere, Carla; Rossetti, Sabrina; D'Aniello, Carmine; Chieffi, Paolo; Amler, Evzen; Buonerba, Carlo; Di Lorenzo, Giuseppe; Di Franco, Rossella; Izzo, Alessandro; Piscitelli, Raffaele; Iovane, Gelsomina; Muto, Paolo; Botti, Gerardo; Perdonà, Sisto; Caraglia, Michele; Facchini, Gaetano.

In: Oncotarget, Vol. 8, No. 61, 01.01.2017, p. 104654-104663.

Research output: Contribution to journalReview article

Boccellino, M, Vanacore, D, Zappavigna, S, Cavaliere, C, Rossetti, S, D'Aniello, C, Chieffi, P, Amler, E, Buonerba, C, Di Lorenzo, G, Di Franco, R, Izzo, A, Piscitelli, R, Iovane, G, Muto, P, Botti, G, Perdonà, S, Caraglia, M & Facchini, G 2017, 'Testicular cancer from diagnosis to epigenetic factors', Oncotarget, vol. 8, no. 61, pp. 104654-104663. https://doi.org/10.18632/oncotarget.20992
Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D'Aniello C et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget. 2017 Jan 1;8(61):104654-104663. https://doi.org/10.18632/oncotarget.20992
Boccellino, Mariarosaria ; Vanacore, Daniela ; Zappavigna, Silvia ; Cavaliere, Carla ; Rossetti, Sabrina ; D'Aniello, Carmine ; Chieffi, Paolo ; Amler, Evzen ; Buonerba, Carlo ; Di Lorenzo, Giuseppe ; Di Franco, Rossella ; Izzo, Alessandro ; Piscitelli, Raffaele ; Iovane, Gelsomina ; Muto, Paolo ; Botti, Gerardo ; Perdonà, Sisto ; Caraglia, Michele ; Facchini, Gaetano. / Testicular cancer from diagnosis to epigenetic factors. In: Oncotarget. 2017 ; Vol. 8, No. 61. pp. 104654-104663.
@article{67edde86a7f442078ff3bde47475b9b0,
title = "Testicular cancer from diagnosis to epigenetic factors",
abstract = "Testicular cancer (TC) is one of the most common neoplasms that occurs in male and includes germ cell tumors (GCT), sex cord-gonadal stromal tumors and secondary testicular tumors. Diagnosis of TC involves the evaluation of serum tumor markers alpha-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase, but clinically several types of immunohistochemical markers are more useful and more sensitive in GCT, but not in teratoma. These new biomarkers are genes expressed in primordial germ cells/gonocytes and embryonic pluripotency-related cells but not in normal adult germ cells and they include PLAP, OCT3/4 (POU5F1), NANOG, SOX2, REX1, AP-2γ (TFAP2C) and LIN28. Gene expression in GCT is regulated, at least in part, by DNA and histone modifications, and the epigenetic profile of these tumours is characterised by genome-wide demethylation. There are different epigenetic modifications in TG-subtypes that reflect the normal developmental switch in primordial germ cells from an under- to normally methylated genome. The main purpose of this review is to illustrate the findings of recent investigations in the classification of male genital organs, the discoveries in the use of prognostic and diagnostic markers and the epigenetic aberrations mainly affecting the patterns of DNA methylation/histone modifications of genes (especially tumor suppressors) and microRNAs (miRNAs).",
keywords = "Biomarkers, Epigenetic factors, Germ cell neoplasia, Seminoma, Testicular cancer",
author = "Mariarosaria Boccellino and Daniela Vanacore and Silvia Zappavigna and Carla Cavaliere and Sabrina Rossetti and Carmine D'Aniello and Paolo Chieffi and Evzen Amler and Carlo Buonerba and {Di Lorenzo}, Giuseppe and {Di Franco}, Rossella and Alessandro Izzo and Raffaele Piscitelli and Gelsomina Iovane and Paolo Muto and Gerardo Botti and Sisto Perdon{\`a} and Michele Caraglia and Gaetano Facchini",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.20992",
language = "English",
volume = "8",
pages = "104654--104663",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "61",

}

TY - JOUR

T1 - Testicular cancer from diagnosis to epigenetic factors

AU - Boccellino, Mariarosaria

AU - Vanacore, Daniela

AU - Zappavigna, Silvia

AU - Cavaliere, Carla

AU - Rossetti, Sabrina

AU - D'Aniello, Carmine

AU - Chieffi, Paolo

AU - Amler, Evzen

AU - Buonerba, Carlo

AU - Di Lorenzo, Giuseppe

AU - Di Franco, Rossella

AU - Izzo, Alessandro

AU - Piscitelli, Raffaele

AU - Iovane, Gelsomina

AU - Muto, Paolo

AU - Botti, Gerardo

AU - Perdonà, Sisto

AU - Caraglia, Michele

AU - Facchini, Gaetano

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Testicular cancer (TC) is one of the most common neoplasms that occurs in male and includes germ cell tumors (GCT), sex cord-gonadal stromal tumors and secondary testicular tumors. Diagnosis of TC involves the evaluation of serum tumor markers alpha-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase, but clinically several types of immunohistochemical markers are more useful and more sensitive in GCT, but not in teratoma. These new biomarkers are genes expressed in primordial germ cells/gonocytes and embryonic pluripotency-related cells but not in normal adult germ cells and they include PLAP, OCT3/4 (POU5F1), NANOG, SOX2, REX1, AP-2γ (TFAP2C) and LIN28. Gene expression in GCT is regulated, at least in part, by DNA and histone modifications, and the epigenetic profile of these tumours is characterised by genome-wide demethylation. There are different epigenetic modifications in TG-subtypes that reflect the normal developmental switch in primordial germ cells from an under- to normally methylated genome. The main purpose of this review is to illustrate the findings of recent investigations in the classification of male genital organs, the discoveries in the use of prognostic and diagnostic markers and the epigenetic aberrations mainly affecting the patterns of DNA methylation/histone modifications of genes (especially tumor suppressors) and microRNAs (miRNAs).

AB - Testicular cancer (TC) is one of the most common neoplasms that occurs in male and includes germ cell tumors (GCT), sex cord-gonadal stromal tumors and secondary testicular tumors. Diagnosis of TC involves the evaluation of serum tumor markers alpha-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase, but clinically several types of immunohistochemical markers are more useful and more sensitive in GCT, but not in teratoma. These new biomarkers are genes expressed in primordial germ cells/gonocytes and embryonic pluripotency-related cells but not in normal adult germ cells and they include PLAP, OCT3/4 (POU5F1), NANOG, SOX2, REX1, AP-2γ (TFAP2C) and LIN28. Gene expression in GCT is regulated, at least in part, by DNA and histone modifications, and the epigenetic profile of these tumours is characterised by genome-wide demethylation. There are different epigenetic modifications in TG-subtypes that reflect the normal developmental switch in primordial germ cells from an under- to normally methylated genome. The main purpose of this review is to illustrate the findings of recent investigations in the classification of male genital organs, the discoveries in the use of prognostic and diagnostic markers and the epigenetic aberrations mainly affecting the patterns of DNA methylation/histone modifications of genes (especially tumor suppressors) and microRNAs (miRNAs).

KW - Biomarkers

KW - Epigenetic factors

KW - Germ cell neoplasia

KW - Seminoma

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=85035331570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035331570&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20992

DO - 10.18632/oncotarget.20992

M3 - Review article

AN - SCOPUS:85035331570

VL - 8

SP - 104654

EP - 104663

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 61

ER -